DV
Dividend Vision

FBT — First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund (FBT)

FBT carries a 0.55% expense ratio. Total return is 1225.0% over the past 20.1 years, 424.0 points ahead of SPY at 801.0%. Its deepest 1-year drawdown was 14.3%.

First Trust NYSE Arca Biotechnology Index Fund is an ETF that tracks an equal-dollar weighted index of 30 leading biotechnology companies, investing at least 90% of its net assets in the index constituents. The fund does not currently distribute income to shareholders and carries an expense ratio of 0.55%. It appeals to investors seeking equity exposure to the biotechnology sector through a passively managed, diversified approach.

FBT key facts

Issuer
First Trust
Asset type
ETF
Asset class
Equity
Inception date
06/19/2006
Expense ratio
0.55%
Distribution frequency
Annual
Last close
$255.42
AUM
$2,770,096,097
Average volume
41300.0
Ex-dividend date
12/13/2024
Payment date
12/31/2024
Beta
0.77
P/E ratio
27.466